Predicting Outcomes of Atezolizumab and Bevacizumab Treatment in Patients with Hepatocellular Carcinoma

被引：12

作者：

Han, Ji Won ^{[1
,2
]}

Jang, Jeong Won ^{[1
,2
]}

机构：

[1] Catholic Univ Korea, Catholic Univ Liver Res Ctr, Coll Med, Seoul 06591, South Korea

[2] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Gastroenterol & Hepatol, Seoul 06591, South Korea

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 14期

基金：

新加坡国家研究基金会;

关键词：

hepatocellular carcinoma; atezolizmumab-bevacizumab; biomarker; TO-LYMPHOCYTE RATIO; PLUS BEVACIZUMAB; ALPHA-FETOPROTEIN; TUMOR; EXPRESSION; CELLS; INTERLEUKIN-6; COMBINATION; SUPPRESSION; SORAFENIB;

D O I：

10.3390/ijms241411799

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A combination of atezolizumab with bevacizumab (AB) is the first regimen that has shown superiority compared to sorafenib and is now being used as the systemic treatment of choice for hepatocellular carcinoma (HCC) patients with Barcelona Liver Cancer Clinic stage C. However, a considerable number of patients do not achieve survival or significant responses, indicating the need to identify predictive biomarkers for initial and on-treatment decisions in HCC patients receiving AB. In this manuscript, we summarized the current data from both experimental and clinical studies. This review will be beneficial for both clinicians and researchers in clinical practice as well as those designing experimental, translational, or clinical studies.

引用

页数：22

共 50 条

[41] A Case of Pseudoprogression in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab [J].

Watanabe, Yukinobu ;

Ogawa, Masahiro ;

Tamura, Yu ;

Suda, Seiichiro ;

Kaneko, Masahiro ;

Kumagawa, Mariko ;

Hirayama, Midori ;

Matsumoto, Naoki ;

Yamamoto, Toshiki ;

Moriyama, Mitsuhiko .

JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2021, 9

[42] Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma [J].

Kinami, Takahiro ;

Uchikawa, Shinsuke ;

Kawaoka, Tomokazu ;

Yamasaki, Shintaro ;

Kosaka, Masanari ;

Johira, Yusuke ;

Yano, Shigeki ;

Amioka, Kei ;

Naruto, Kensuke ;

Yamaoka, Kenji ;

Fujii, Yasutoshi ;

Fujino, Hatsue ;

Nakahara, Takashi ;

Ono, Atsushi ;

Murakami, Eisuke ;

Okamoto, Wataru ;

Yamauchi, Masami ;

Miki, Daiki ;

Tsuge, Masataka ;

Oka, Shiro .

CANCER MEDICINE, 2024, 13 (05)

[43] Atezolizumab plus bevacizumab in patients with child-Pugh B advanced hepatocellular carcinoma [J].

Cheon, Jaekyung ;

Kim, Hyeyeong ;

Kim, Han Sang ;

Kim, Chang Gon ;

Kim, Ilhwan ;

Kang, Beodeul ;

Kim, Chan ;

Jung, Sanghoon ;

Ha, Yeonjung ;

Chon, Hong Jae .

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15

[44] The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab [J].

Takeuchi, Yasuto ;

Nouso, Kazuhiro ;

Fujioka, Shin-ichi ;

Kariyama, Kazuya ;

Kobashi, Haruhiko ;

Uematsu, Shuji ;

Moriya, Akio ;

Hagihara, Hiroaki ;

Takabatake, Hiroyuki ;

Nakamura, Shinichiro ;

Yabushita, Kazuhisa ;

Kikuchi, Tatsuya ;

Oyama, Atsushi ;

Adachi, Takuya ;

Wada, Nozomu ;

Onishi, Hideki ;

Shiraha, Hidenori ;

Takaki, Akinobu .

CANCER MEDICINE, 2023, 12 (17) :17559-17568

[45] Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment [J].

Chon, Young Eun ;

Cheon, Jaekyung ;

Kim, Hyeyeong ;

Kang, Beodeul ;

Ha, Yeonjung ;

Kim, Do Young ;

Hwang, Seong Gyu ;

Chon, Hong Jae ;

Kim, Beom Kyung .

CANCER MEDICINE, 2023, 12 (03) :2731-2738

[46] Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience [J].

Sinner, Friedrich ;

Pinter, Matthias ;

Scheiner, Bernhard ;

Ettrich, Thomas Jens ;

Sturm, Niklas ;

Gonzalez-Carmona, Maria A. ;

Waidmann, Oliver ;

Finkelmeier, Fabian ;

Himmelsbach, Vera ;

De Toni, Enrico N. ;

Ben Khaled, Najib ;

Mohr, Raphael ;

Fruendt, Thorben Wilhelm ;

Kuetting, Fabian ;

van Boemmel, Florian ;

Lieb, Sabine ;

Krug, Sebastian ;

Bettinger, Dominik ;

Schultheiss, Michael ;

Jochheim, Leonie S. ;

Best, Jan ;

Mueller, Christian ;

Keitel, Verena ;

Venerito, Marino .

CANCERS, 2022, 14 (23)

[47] Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis [J].

Tada, Toshifumi ;

Kumada, Takashi ;

Hiraoka, Atsushi ;

Hirooka, Masashi ;

Kariyama, Kazuya ;

Tani, Joji ;

Atsukawa, Masanori ;

Takaguchi, Koichi ;

Itobayashi, Ei ;

Fukunishi, Shinya ;

Tsuji, Kunihiko ;

Ishikawa, Toru ;

Tajiri, Kazuto ;

Ochi, Hironori ;

Yasuda, Satoshi ;

Toyoda, Hidenori ;

Ogawa, Chikara ;

Nishimura, Takashi ;

Hatanaka, Takeshi ;

Kakizaki, Satoru ;

Shimada, Noritomo ;

Kawata, Kazuhito ;

Tanaka, Takaaki ;

Ohama, Hideko ;

Nouso, Kazuhiro ;

Morishita, Asahiro ;

Tsutsui, Akemi ;

Nagano, Takuya ;

Itokawa, Norio ;

Okubo, Tomomi ;

Arai, Taeang ;

Imai, Michitaka ;

Naganuma, Atsushi ;

Koizumi, Yohei ;

Nakamura, Shinichiro ;

Joko, Kouji ;

Iijima, Hiroko ;

Hiasa, Yoichi .

CANCER MEDICINE, 2022, 11 (20) :3796-3808

[48] Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study [J].

Tanaka, Kazunari ;

Tsuji, Kunihiko ;

Hiraoka, Atsushi ;

Tada, Toshifumi ;

Hirooka, Masashi ;

Kariyama, Kazuya ;

Tani, Joji ;

Atsukawa, Masanori ;

Takaguchi, Koichi ;

Itobayashi, Ei ;

Fukunishi, Shinya ;

Ishikawa, Toru ;

Tajiri, Kazuto ;

Ochi, Hironori ;

Toyoda, Hidenori ;

Ogawa, Chikara ;

Nishimura, Takashi ;

Hatanaka, Takeshi ;

Kakizaki, Satoru ;

Shimada, Noritomo ;

Kawata, Kazuhito ;

Naganuma, Atsushi ;

Kosaka, Hisashi ;

Matono, Tomomitsu ;

Kuroda, Hidekatsu ;

Yata, Yutaka ;

Ohama, Hideko ;

Tada, Fujimasa ;

Nouso, Kazuhiro ;

Morishita, Asahiro ;

Tsutsui, Akemi ;

Nagano, Takuya ;

Itokawa, Norio ;

Okubo, Tomomi ;

Arai, Taeang ;

Yokohama, Keisuke ;

Nishikawa, Hiroki ;

Imai, Michitaka ;

Koizumi, Yohei ;

Nakamura, Shinichiro ;

Iijima, Hiroko ;

Kaibori, Masaki ;

Hiasa, Yoichi ;

Kumada, Takashi .

CANCERS, 2023, 15 (17)

[49] Three effective cases of transcatheter arterial embolization after atezolizumab and bevacizumab treatment for hepatocellular carcinoma: a case report [J].

Rinka, Koji ;

Kioka, Kiyohide ;

Amano, Yuga ;

Nakai, Takashi ;

Kawasaki, Yasuko ;

Kawada, Norifumi .

JOURNAL OF MEDICAL CASE REPORTS, 2025, 19 (01)

[50] Considering nutritional status to improve outcomes of patients treated by atezolizumab-bevacizumab for advanced hepatocellular carcinoma [J].

Allaire, Manon ;

Avila, Matias A. .

LIVER INTERNATIONAL, 2024, 44 (06) :1276-1277

← 1 2 3 4 5 →